tirzepatide taken off market FDA declares Mounjaro, Zepbound shortage over FDA says shortage of GLP-1

Oral iron supplementation (typically ferrous sulphate 200 mg once daily or on alternate days) is first-line treatment for uncomplicated iron deficiency

Such comprehensive care will support treatment benefits beyond body weight alone and will make clinicians more effective stewards of GLP-1s and, ultimately, of patients overall health

Fatigue is a possible side effect, but depression is not commonly linked to Ozempic use

drug spending despite being only 5% of prescriptions

No claw-backs, no prior authorizations, just straightforward transactions

The combination lacks clinical trial data establishing safety and efficacy